Page 10 - PCC10

Introduction
Human embryonic stem cells (hESC). Induced pluripotent stem cells (hiPSC) Banking pluripotent stem cells Informed consent.
Provenance and selection of donor tissue Donor selection and risk factors Traceability and identifiability
Characterization and quality control Banks and registries
Cell therapy
Clinical grade lines
GMP conditions Clinical trials
PCC Stem Cells - ESHRE BCN 2018
Pluripotent Stem Cells can be obtained from cells located in the inner cell mass of blastocysts, early embryos and isolated blastomeres (hESC) and from nuclear reprogramming (Somatic Cell Nuclear Transfer - SCNTand induced Pluripotent Stem Cells - iPS)
PCC Stem Cells - ESHRE BCN 2018
Page 4 of 135
10